Professor of Health Policy and Administration
School of Public Health
University of Illinois at Chicago (UIC)
J. Warren Salmon, Ph.D. was Professor of Health Policy and Administration, School of Public Health at the University of Illinois at Chicago (UIC), now retired but actively engaged in research still. He was formerly a Professor in and Head of the Department of Pharmacy Administration, College of Pharmacy; Professor of Public Policy Analysis, College of Urban Planning and Public Affairs; and Professor of Medical Education, College of Medicine at UIC. Professor Salmon's research interests have focused on the corporatization of medicine and pharmacy, managed care pharmacy, urban health care delivery, comparative health care systems, global pharmaceutical industry developments, and alternative and complimentary medicines.
Nanotechnology and Advanced Materials (NATAM)
Chemical and Nanopharmaceutical Process Engineering
Professor Sivakumar Manickam is a Chemical Engineer specializing Process Engineering of Nanomaterials especially Nanopharmaceuticals. He is working in the area of Ultrasound and Hydrodynamic Cavitation since 1997. Presently he is working with University of Nottingham, Malaysia campus and his research group concentrates on the process development of cavitation based reactors towards technologically important nanomaterials. He is also heading the Manufacturing and Industrial Processes Research Division and is the Coordinator of the Centre for Nanotechnology and Advanced Materials (CENTAM). He was also the recipient of prestigious JSPS fellowship from the Government of Japan. He has published ~150 peer reviewed journal and conference papers. He is the Fellow of Higher Education Academy (UK) and member of Institute of Nanotechnology (IoN).
UNESCO Chair-Life Sciences International
Postgraduate Educational Center
Prof. Sinerik Ayrapetyan has received his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev during the period of 1966-1970. Currently, he is the coordinator of UNESCO Chair at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. He has successfully completed his Administrative responsibilities as the president of Life Sciences International Postgraduate Educational Center. His research has included the study of metabolic regulation of cell function in norm and pathology. He is serving as an editorial member of several reputed journals like “Electromagnetic Biology and Medicine”, “ISRN Biophysics”, “European Journal of Biophysics”, “Advances in Life Sciences", “Bioavailability and Bioequivalence”, “Applied Pharmacy”, “BBA General Subjects”, “International Dental and Medical Research", “International Journal of Basic and Applied Sciences” & expert Reviewer for journals like “Brain research”, “Radiobiology”, “Bioelectromagnetics”, “Journal of Alzheimer’s diseases”, “Life Sciences” etc. He has authored 7 international books and 115 research articles.
Prof. XU, Baojun Bruce is a Professor of Food Science and Technology department at University of Illinois at Chicago, USA.
His research interest includes 1) health benefits (targeted at aging, cancers, obesity, diabetes, and inflammatory diseases) assessment of phytochemicals from legumes, fruits, vegetables, traditional Chinese medicines through in vitro animal cell models; 2) cellular and molecular mechanisms of bioactive food components in disease prevention; 3) development of novel health promoting products and cosmeceuticals; 4) lab-scale and pilot scale extraction techniques of natural functional polysaccharides.
David W. Moskowitz, viagra discount MD- Chairman, Therapy Chief Executive Officer, and Chief Medical Officer, Florida
Dr. Moskowitz majored in Chemistry (summa cum laude) at Harvard College, Biochemistry (first class honours) at Merton College, Oxford, and received an MD (cum laude) from the Harvard-MIT Division in Health Sciences and Technology (Harvard Medical School). He trained for 7 years in Internal Medicine, Biochemistry, and Nephrology at Washington University School of Medicine in St. Louis before spending 11 years on the faculty of St. Louis University School of Medicine. Since 1994, Dr. Moskowitz has experienced first hand the clinical effectiveness of knowing a disease-associated gene (the angiotensin converting enzyme, or ACE, gene). Dr. Moskowitz is a pioneer in the field of medical genomics, and has been recognized for his groundbreaking treatment of diseases associated with the angiotensin I-converting enzyme, such as chronic renal failure due to hypertension or type II diabetes.
Professor, Microbiology and Immunology
Professor, Center for Translational Medicine
Temple University, USA
Dr. Praticò’s research area is clinical pharmacology with a special focus on the cellular and molecular aspects of cell oxidative biology and a particular interest in small molecules such as bioactive oxidized lipids.
This area is very broad and extends to multiple disciplines including aging, cardiovascular diseases as well as neurodegeneration. Our work in the biology of oxidized bioactive lipids has significantly contributed to the current understanding of their importance as biomarkers, mediators of cellular and molecular events involved in the pathogenesis of several clinical conditions, and therapeutic targets for preventing and treating human diseases. In our lab we employ cellular and animal models of human diseases, and in this context particular emphasis is given to the translation of any observation made in these systems into a better understanding of human physiology and pathology. Our group is committed to foster collaborative scientific research of the highest quality, and at the same time to provide outstanding teaching and mentoring for young scientists.
Founder, Oxford Molecular
Chairmen, Inhibox Limited
Oxford center of innovation
Prof. Graham Richards CBE recently retired from Oxford University where he was Head of the Department of Chemistry 1997-2006, the world’s biggest chemistry department. His research focused on the applications of theoretical chemistry to drug discovery and he devised the widely publicized screensaver project which involved over 3.5 million personal computers in more than 200 countries. He now operates from the drug discovery company Inhibox Ltd.
He is the author of over 360 scientific papers and 18 books, including ‘Spin- outs: creating businesses from university intellectual property’ and the recently published ‘University Intellectual Property: a source of finance and impact’. He has consulted for several major pharma companies and is now senior non-executive director of IP Group Plc as well as holding a number of other directorships of biotechnology companies.